Skip to content
AkademScholar

Products

For developers

AkademBasesoonDeveloper API
Journal

Infusion & Chemotherapy

ISSN:
2663-0338
0
h-index
0
Citations
12
Works

Trust signals

1 of 3 signals present

Independent positive signals — not a single “predatory/legitimate” verdict, but a converging picture.

  • DOAJ
    No data
    doaj.org
  • OAK list
    No data
    OAK
  • Valid ISSN
    Present
    ISSN

This is an information label, not an official ruling. A missing signal is not a penalty — a regional journal may simply not be in DOAJ.

Trends over time

Performance over time

Citation overview

Publications (bars) and citations (line) by year

  • Publications
  • Citations
0358100120202021202220232020: Publications 9, Citations 02021: Publications 1, Citations 02022: Publications 1, Citations 02023: Publications 1, Citations 0

Publication history

03581020202021202220232020: Publications 92021: Publications 12022: Publications 12023: Publications 1

h-index evolution

Cumulative h-index by year

0120202021202220232020: h-index 02021: h-index 02022: h-index 02023: h-index 0

Most-cited works

  1. Massive obstetric bleeding: optimization of total hysterectomy surgery technique and conservative treatment20200 citations
  2. Obstetric blood loss: priorities in the infusion solutions choice20200 citations
  3. Possibilities of the correction of placental dysfunction in women with preeclampsia20200 citations
  4. The influence of myocardoprotection on the course of postinfarction chronic heart failure20200 citations
  5. Infusion therapy in treatment of patients with acute coronary syndrome20200 citations
  6. The relevance of infusion and transfusion therapy in obstetric practice20200 citations
  7. Options of the placental dysfunction correction in women with preeclampsia20200 citations
  8. Obstetric blood loss: priorities in the choice of infusion solutions20200 citations
  9. Endothelial dysfunction and its role in the prevention, treatment and complications of critical conditions in obstetrics20200 citations
  10. The first data on international multicenter clinical study RheoSTAT-CP0698 on the efficacy and safety of Rheosorbilact® infusion in therapy of pneumonia20210 citations